sars-cov-2

Documents about sars-cov-2

• Vitamin D Supplementarion in Pregnant Women at Risk and COVID-19#869537ClinicalTrials.gov
• Cytokine and Eicosanoid Mediators in Coronavirus Disease 2019 (COVID-19)#877385ClinicalTrials.gov
• Collection of RNA Extracted From Nasopharyngeal and Saliva Samples From Same Patients With Suspicion of Covid-19#879193ClinicalTrials.gov
• Open Multicenter Study for Assessment of Efficacy and Safety of Molnupiravir in Adult Patients With COVID-19#881612ClinicalTrials.gov
• COVID-19: A Trial Studying the SARS-CoV-2 mRNA Vaccine CVnCoV to Learn About the Immune Response, the Safety, and the Degree of Typical Vaccination Reactions When CVnCoV is Given at the Same Time as a Flu Vaccine Compared to When the Vaccines Are Separately Given in Adults 60 Years of Age and Older#290850ClinicalTrials.gov
• The impact of the COVID-19 pandemic on osteoporotic fractures: a systematic review and meta-analysis#5189Europe PMC
• Impact of in-hospital SARS-CoV-2 infection on mortality and outcomes in patients admitted for heart failure: a nationwide analysis in Brazil.#14997NCBI PubMed Central
• Views on consent approaches used in emergency and critical care research: a rapid, systematic review.#25940PubMed
• Evaluation of the Immunogenicity and Safety of Ad26.COV2.S's COVID-19 Vaccine#123540ClinicalTrials.gov
• A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19#141084ClinicalTrials.gov
• QoALa: A comprehensive workflow for viral quasispecies diversity comparison using long-read sequencing data#141252PLOS
• Heterologous Boost Immunization with an Aerosolised Ad5-nCoV After Two-dose Priming with an Inactivated SARS-CoV-2 Vaccine#158022ClinicalTrials.gov
• Opposing and antagonizing effects of SARS-CoV-2/COVID-19 infection and recombinant zoster vaccination on the risk of late-onset Alzheimer disease#200178bioRxiv / medRxiv
• Modeling the impact of adherence to U.S. isolation and masking guidance on SARS-CoV-2 transmission in office workplaces in 2021-2022#210518bioRxiv / medRxiv
• Data for "Life course malaria exposure and SARS-CoV-2 Sero-epidemiology in Ugandan adolescents: a longitudinal study nested in a birth cohort"#235506LSHTM Data Compass
• SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry#254348IRIS
• Is sitagliptin effective for SARS-CoV-2 infection: false or true prophecy?#262006HAL (France)
• Cholinergic dysfunction in COVID-19: frantic search and hoping for the best#280247HAL (France)
• Combining machine learning and iterative experiments to keep pace with emerging viral variants of concern#289111PLOS
• Deep mutational scanning reveals the antibody escape and infectivity landscape of SARS-CoV-2 Omicron JN.1 and XEC receptor-binding domains.#308811NCBI PubMed Central
• A Study to Determine Safety and Immunogenicity of the Candidate COVID-19 Vaccine AZD1222 Delivered by Aerosol in Healthy Adult Volunteers#311200ClinicalTrials.gov
• Développement et optimisation de protocoles de la cryo-microscopie électronique de l’échelle nanométrique à l’échelle micrométrique#325996HAL (France)
• A Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273 Vaccine in Adolescents 12 to <18 Years Old to Prevent COVID-19#329585ClinicalTrials.gov
• Phase II/III Study of the AVX/COVID-12 Vaccine Against COVID-19 Applied as a Booster.#343720ClinicalTrials.gov
• A Study to Evaluate the Safety and Immunogenicity of Vaccine CVnCoV in Healthy Adults in Germany for COVID-19#366649ClinicalTrials.gov
• Evolution of SARS-CoV-2 caused infection in farmed minks: continuous surveillance of an 11-month outbreak at the largest Latvian mink farm.#371480NCBI PubMed Central
• Bioluminate and Osprey data - A comprehensive study of SARS-CoV-2 main protease (Mpro) inhibitor-resistant mutants selected in a VSV-based system#401086Universität Innsbruck
• Repetitive mRNA vaccination is required to improve the quality of broad-spectrum anti-SARS-CoV-2 antibodies in the absence of CXCL13#418023HAL (France)
• Harmonization of Real-World Data for Vaccine-Preventable Infectious Diseases: Integration of SARS-CoV-2 Diagnostic and Serologic Data From Multiple Sources.#433879NCBI PubMed Central
• Clinical Characteristics of COVID-19: Use of Steroids in Mostly Unvaccinated COVID-19 Patients Before the Omicron Variant#450665S-Space: Seoul National University
• Nanoscopy reveals heparan sulfate clusters as docking sites for SARS-CoV-2 attachment and entry#484954Europe PMC
• Interactomics of SARS-CoV-2 Macrodomain 1 Reveals Putative Clients of ADP-Ribosyl Hydrolase Activity#485254Europe PMC
• Is There a Relationship between Hyperventilation Syndrome and History of Acute SARS-CoV-2 Infection? A Cross-Sectional Study#643346HAL (France)
• Pandemic research in a small island society-a narrative review of research contributions during the SARS-CoV-2 pandemic in the Faroe Islands.#645202NCBI PubMed Central
• Vaccine Immunogenicity and Safety in ImmunoDeficient Patients [VISID, study data contributed to the CITF Databank]#657720Borealis Dataverse OAI Archive
• Head-to-head evaluation of seven different seroassays including direct viral neutralisation in a representative cohort for SARS-CoV-2#779272Bielefeld Pub
• In-vitro Diagnostic Test to Predict COVID-19 Mortality and Disease Severity#800486ClinicalTrials.gov
• Lot-to-lot Consistency of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Healthy Adults#805571ClinicalTrials.gov
• A Clinical Trial of Immuno-bridging Between Different Manufacture Scales of Recombinant COVID-19 Vaccine (Sf9 Cell)#860801ClinicalTrials.gov
• Study of Merimepodib in Combination With Remdesivir in Adult Patients With Advanced COVID-19#866121ClinicalTrials.gov
• Masitinib Combined With Isoquercetin and Best Supportive Care in Hospitalized Patients With Moderate and Severe COVID-19#871364ClinicalTrials.gov
• Prevalence of Knowledge, Attitudes and Perception of Covid Vaccine in Iraq. A Cross Sectional Study#873203ClinicalTrials.gov
• Safety and Immunogenicity of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) for the Prevention of COVID-19#882129ClinicalTrials.gov
• COVID-19 Surveillance in Rural Mozambique for Prompt and Effective Response#882373ClinicalTrials.gov
• Development of nanobody-displayed whole-cell biosensors for the colorimetric detection of SARS-CoV‑2#683800DSpace
• Desarrollo de un protocolo de clonamiento de las proteínas recombinantes del virus SARS-COV-2 NUCLEOCAPSIDE y ORF3B para ampliar el análisis de la respuesta humoral en COVID-19.#626510Repositorio
• A Novel Coronavirus from Patients with Pneumonia in China, 2019#6811OpenAlex
• An interactive web-based dashboard to track COVID-19 in real time#6906OpenAlex
• Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation#6968OpenAlex
• The socio-economic implications of the coronavirus pandemic (COVID-19): A review#7289OpenAlex